Clinical Trial Update: A Study of a Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR) in Participants With Mild Cognitive Impairment

View source ↗

Summary

The clinical trial SAMSTAR evaluating a self-administered memory screening test in mild cognitive impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Mild Cognitive Impairment | Status: COMPLETED